Lee Philina

Track

Insider profile

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 95% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Lee Philina's trades of Blueprint Medicines Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
118.71
Quantity 90,353
Value US$4,621,961
Transaction date
Proposed sale
Price
89.00
Quantity 8,023
Value US$714,047
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-07 2025-03-05
S Sale
58,543 -7.1%
43.81
US$1,674,088 		58,543 -7.1% 43.81 US$1,674,088
2024-08-07 2024-08-05
S Sale
82,412 -40.7%
411.88
US$1,428,350 		82,412 -40.7% 411.88 US$1,428,350
2024-08-05 2024-08-05
PrS Proposed sale
90,353
118.71
US$4,621,961 		90,353 118.71 US$4,621,961
2024-03-15 2024-03-13
S Sale
1,800 -4.9%
89.88
US$161,784 		1,800 -4.9% 89.88 US$161,784
2024-03-15 2024-03-13
S Sale
6,223 -14.6%
90.55
US$563,493 		6,223 -14.6% 90.55 US$563,493
2024-03-13 2024-03-13
PrS Proposed sale
8,023
89.00
US$714,047 		8,023 89.00 US$714,047
2024-03-11 2024-03-07
S Sale
2,934 -6.7%
90.69
US$266,084 		2,934 -6.7% 90.69 US$266,084
2023-03-08 2023-03-06
S Sale
54 -0.2%
44.40
US$2,398 		54 -0.2% 44.40 US$2,398
2023-03-08 2023-03-06
S Sale
1,622 -4.9%
45.72
US$74,158 		1,622 -4.9% 45.72 US$74,158